• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Covid-19 间质性肺炎:冷冻活检的组织学和免疫组织化学特征。

Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies.

机构信息

Department of Pathology, University Vita-Salute, Milan and San Raffaele Scientific Institute, Milan, Italy.

Pulmonology Unit, Thoracic Diseases Department, G.B. Morgagni Hospital, Forlì, Italy,

出版信息

Respiration. 2021;100(6):488-498. doi: 10.1159/000514822. Epub 2021 Mar 16.

DOI:10.1159/000514822
PMID:33725700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8018216/
Abstract

BACKGROUND

The pathogenetic steps leading to Covid-19 interstitial pneumonia remain to be clarified. Most postmortem studies to date reveal diffuse alveolar damage as the most relevant histologic pattern. Antemortem lung biopsy may however provide more precise data regarding the earlier stages of the disease, providing a basis for novel treatment approaches.

OBJECTIVES

To ascertain the morphological and immunohistochemical features of lung samples obtained in patients with moderate Covid-19 pneumonia.

METHODS

Transbronchial lung cryobiopsy was carried out in 12 Covid-19 patients within 20 days of symptom onset.

RESULTS

Histopathologic changes included spots of patchy acute lung injury with alveolar type II cell hyperplasia, with no evidence of hyaline membranes. Strong nuclear expression of phosphorylated STAT3 was observed in >50% of AECII. Interalveolar capillaries showed enlarged lumen and were in part arranged in superposed rows. Pulmonary venules were characterized by luminal enlargement, thickened walls, and perivascular CD4+ T-cell infiltration. A strong nuclear expression of phosphorylated STAT3, associated with PD-L1 and IDO expression, was observed in endothelial cells of venules and interstitial capillaries. Alveolar spaces macrophages exhibited a peculiar phenotype (CD68, CD11c, CD14, CD205, CD206, CD123/IL3AR, and PD-L1).

CONCLUSIONS

Morphologically distinct features were identified in early stages of Covid-19 pneumonia, with epithelial and endothelial cell abnormalities different from either classical interstitial lung diseases or diffuse alveolar damage. Alveolar type II cell hyperplasia was a prominent event in the majority of cases. Inflammatory cells expressed peculiar phenotypes. No evidence of hyaline membranes and endothelial changes characterized by IDO expression might in part explain the compliance and the characteristic pulmonary vasoplegia observed in less-advanced Covid-19 pneumonia.

摘要

背景

导致 COVID-19 间质性肺炎的发病步骤仍有待阐明。迄今为止,大多数尸检研究揭示弥漫性肺泡损伤是最相关的组织学模式。然而,生前肺活检可能提供有关疾病早期阶段的更精确数据,为新的治疗方法提供依据。

目的

确定中度 COVID-19 肺炎患者肺样本的形态学和免疫组织化学特征。

方法

在症状发作后 20 天内对 12 例 COVID-19 患者进行经支气管肺冷冻活检。

结果

组织病理学变化包括局灶性斑片状急性肺损伤,伴有肺泡 II 型细胞增生,无透明膜证据。超过 50%的 AECII 中观察到磷酸化 STAT3 的强核表达。肺泡毛细血管腔扩大,部分呈重叠排列。肺小静脉表现为管腔扩大、壁增厚和血管周围 CD4+T 细胞浸润。小静脉和间质毛细血管内皮细胞中观察到磷酸化 STAT3 的强核表达,与 PD-L1 和 IDO 表达相关。肺泡腔巨噬细胞表现出独特的表型(CD68、CD11c、CD14、CD205、CD206、CD123/IL3AR 和 PD-L1)。

结论

在 COVID-19 肺炎的早期阶段确定了形态学上不同的特征,上皮和内皮细胞异常与经典间质性肺疾病或弥漫性肺泡损伤不同。大多数情况下,II 型肺泡细胞增生是一个突出的事件。炎症细胞表达独特的表型。无透明膜和内皮细胞改变的证据,其特征是 IDO 表达,可能部分解释了在不太严重的 COVID-19 肺炎中观察到的顺应性和特征性肺血管舒张。

相似文献

1
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies.Covid-19 间质性肺炎:冷冻活检的组织学和免疫组织化学特征。
Respiration. 2021;100(6):488-498. doi: 10.1159/000514822. Epub 2021 Mar 16.
2
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime.上皮细胞和内皮细胞在新冠肺炎早期肺炎中的致病作用:同谋与共犯。
Mod Pathol. 2021 Aug;34(8):1444-1455. doi: 10.1038/s41379-021-00808-8. Epub 2021 Apr 21.
3
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection.SARS-CoV-2 感染后持续性肺部疾病患者的临床、影像学和病理学表现。
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02411-2021. Print 2022 Oct.
4
Histopathological pulmonary findings of survivors and autopsy COVID-19 cases: A bi-center study.幸存者和尸检 COVID-19 病例的组织病理学肺部发现:一项双中心研究。
Medicine (Baltimore). 2022 Nov 25;101(47):e32002. doi: 10.1097/MD.0000000000032002.
5
Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.新型冠状病毒疾病 2019 感染导致的弥漫性肺泡损伤(DAD)在形态上与其他 DAD 病因无法区分。
Histopathology. 2020 Oct;77(4):570-578. doi: 10.1111/his.14180. Epub 2020 Sep 12.
6
Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations.轻型 SARS-CoV-2 间质性肺炎的病理生理学:从组织病理学特征到临床表现。
Pulmonology. 2022 Sep-Oct;28(5):333-344. doi: 10.1016/j.pulmoe.2021.03.003. Epub 2021 Mar 26.
7
Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2.生前与死后经支气管镜活检标本和尸检肺组织样本的组织病理学和超微结构观察:三例确诊 SARS-CoV-2 患者的对比研究。
Am J Clin Pathol. 2022 Jan 6;157(1):54-63. doi: 10.1093/ajcp/aqab087.
8
[A pathological report of three COVID-19 cases by minimal invasive autopsies].[三例新冠病毒病病例微创尸检病理报告]
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417. doi: 10.3760/cma.j.cn112151-20200312-00193.
9
[Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].[2019年新型冠状病毒肺炎(COVID-19)致死病例肺部病理改变:经皮针吸尸检10例报告]
Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):568-575. doi: 10.3760/cma.j.cn112151-20200405-00291.
10
Evolution of pulmonary pathology in severe acute respiratory syndrome.重症急性呼吸综合征肺部病理的演变
J Formos Med Assoc. 2005 Feb;104(2):75-81.

引用本文的文献

1
Evaluation and Characterization of Acute respiratory distress syndrome in tree shrews through TMT proteomic method.通过TMT蛋白质组学方法对树鼩急性呼吸窘迫综合征的评估与表征
PLoS One. 2025 Apr 16;20(4):e0319752. doi: 10.1371/journal.pone.0319752. eCollection 2025.
2
Cause of Death Analysis in a 9½-Year-Old with COVID-19 and Dravet Syndrome.一名9岁半的新冠病毒病(COVID-19)合并德雷维特综合征患儿的死因分析
Pathophysiology. 2025 Jan 10;32(1):3. doi: 10.3390/pathophysiology32010003.
3
Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalities.经支气管钳取活检用于诊断与 COVID-19 相关的弥漫性肺实质异常。
BMC Pulm Med. 2024 Dec 23;24(1):631. doi: 10.1186/s12890-024-03449-0.
4
The association of radiologic right heart strain indices with the severity of pulmonary parenchymal involvement and prognosis in patients with COVID-19.新型冠状病毒肺炎患者放射学右心应变指标与肺实质受累严重程度及预后的相关性
J Cardiovasc Thorac Res. 2024;16(3):171-178. doi: 10.34172/jcvtr.33094. Epub 2024 Sep 20.
5
FOT Technique Applied for Monitoring of COVID-19 Pneumonia Reveals Small Airways Involvement.应用FOT技术监测新冠肺炎肺炎显示小气道受累。
Diagnostics (Basel). 2024 May 31;14(11):1160. doi: 10.3390/diagnostics14111160.
6
Kynurenine Pathway in Respiratory Diseases.呼吸系统疾病中的犬尿氨酸途径
Int J Tryptophan Res. 2024 Mar 14;17:11786469241232871. doi: 10.1177/11786469241232871. eCollection 2024.
7
Lung Ultrasound Score as a Predictor of Failure to Wean COVID-19 Elderly Patients off Mechanical Ventilation: A Prospective Observational Study.肺部超声评分对预测 COVID-19 老年患者脱机率机械通气失败的作用:一项前瞻性观察研究。
Clin Interv Aging. 2024 Feb 19;19:313-322. doi: 10.2147/CIA.S438714. eCollection 2024.
8
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium.支气管肺泡灌洗在新型冠状病毒肺炎中的应用:来自“龙”联盟的观点
Front Med (Lausanne). 2024 Feb 2;11:1259570. doi: 10.3389/fmed.2024.1259570. eCollection 2024.
9
Post-COVID-19 pulmonary fibrosis: An ongoing concern.新冠病毒感染后肺纤维化:持续受到关注。
Ann Thorac Med. 2023 Oct-Dec;18(4):173-181. doi: 10.4103/atm.atm_7_23. Epub 2023 Oct 17.
10
COVID-19 and lung cancer.新型冠状病毒肺炎与肺癌。
Pathologica. 2023 Oct;115(5):284-291. doi: 10.32074/1591-951X-908.

本文引用的文献

1
Reversibility of venous dilatation and parenchymal changes density in Sars-Cov-2 pneumonia: toward the definition of a peculiar pattern.新型冠状病毒肺炎中静脉扩张和实质密度变化的可逆性:迈向一种特殊模式的定义
Pulmonology. 2021 Jul-Aug;27(4):353-357. doi: 10.1016/j.pulmoe.2020.10.010. Epub 2020 Nov 16.
2
IDO Expression in Cancer: Different Compartment, Different Functionality?IDO 在癌症中的表达:不同部位,不同功能?
Front Immunol. 2020 Sep 24;11:531491. doi: 10.3389/fimmu.2020.531491. eCollection 2020.
3
Microvascular dysfunction in COVID-19: the MYSTIC study.新型冠状病毒肺炎中的微血管功能障碍:MYSTIC 研究。
Angiogenesis. 2021 Feb;24(1):145-157. doi: 10.1007/s10456-020-09753-7. Epub 2020 Oct 14.
4
Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.新型冠状病毒病 2019 与严重急性呼吸综合征和 H1N1 流感的肺部组织病理学比较:系统综述。
Chest. 2021 Jan;159(1):73-84. doi: 10.1016/j.chest.2020.09.259. Epub 2020 Oct 7.
5
An aberrant STAT pathway is central to COVID-19.异常的 STAT 通路是 COVID-19 的核心。
Cell Death Differ. 2020 Dec;27(12):3209-3225. doi: 10.1038/s41418-020-00633-7. Epub 2020 Oct 9.
6
Autopsy findings in COVID-19-related deaths: a literature review.COVID-19 相关死亡的尸检结果:文献综述。
Forensic Sci Med Pathol. 2021 Jun;17(2):279-296. doi: 10.1007/s12024-020-00310-8. Epub 2020 Oct 7.
7
SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response.SARS-CoV-2 感染多能干细胞衍生的人肺Ⅱ型肺泡细胞会引发快速的上皮细胞固有炎症反应。
Cell Stem Cell. 2020 Dec 3;27(6):962-973.e7. doi: 10.1016/j.stem.2020.09.013. Epub 2020 Sep 18.
8
Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation - A Case-Control Study.COVID-19 肺炎患者在长时间有创机械通气期间发生气压伤的发生率 - 一项病例对照研究。
J Intensive Care Med. 2021 Apr;36(4):477-483. doi: 10.1177/0885066620954364. Epub 2020 Sep 22.
9
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.COVID-19 相关性急性呼吸窘迫综合征的病理生理学:一项多中心前瞻性观察研究。
Lancet Respir Med. 2020 Dec;8(12):1201-1208. doi: 10.1016/S2213-2600(20)30370-2. Epub 2020 Aug 27.
10
Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19.免疫检查点抑制剂对病毒感染和新冠肺炎的潜在保护及治疗作用。
Immunotherapy. 2020 Oct;12(15):1111-1114. doi: 10.2217/imt-2020-0109. Epub 2020 Jun 29.